Literature DB >> 12578222

Inflammatory mechanisms after ischemia and stroke.

Gary H Danton1, W Dalton Dietrich.   

Abstract

Inflammation has been implicated as a secondary injury mechanism following ischemia and stroke. A variety of experimental models, including thromboembolic stroke, focal and global ischemia, have been used to evaluate the importance of inflammation. The vasculature endothelium promotes inflammation through the upregulation of adhesion molecules such as ICAM, E-selectin, and P-selectin that bind to circulating leukocytes and facilitate their migration into the CNS. Once in the CNS, the production of cytotoxic molecules may facilitate cell death. The macrophage and microglial response to injury may either be beneficial by scavenging necrotic debris or detrimental by facilitating cell death in neurons that would otherwise recover. While many studies have tested these hypotheses, the importance of inflammation in these models is inconclusive. This review summarizes data regarding the role of the vasculature, leukocytes, blood-brain barrier, macrophages, and microglia after experimental and clinical stroke.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578222     DOI: 10.1093/jnen/62.2.127

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  180 in total

1.  Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.

Authors:  Le Wu; Sen Miao; Lin-Bing Zou; Ping Wu; Hua Hao; Ke Tang; Pan Zeng; Jing Xiong; Hong-Hua Li; Qiang Wu; Lei Cai; Du-Yun Ye
Journal:  J Mol Neurosci       Date:  2012-06-03       Impact factor: 3.444

2.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 3.  The search for neuroprotective strategies in stroke.

Authors:  Gary H Danton; W Dalton Dietrich
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

4.  Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.

Authors:  Attila D Kovács; Angelika Saje; Andrew Wong; Serena Ramji; Jonathan D Cooper; David A Pearce
Journal:  Neuropharmacology       Date:  2012-06-06       Impact factor: 5.250

5.  Differential effects of aging and sex on stroke induced inflammation across the lifespan.

Authors:  Bharti Manwani; Fudong Liu; Victoria Scranton; Matthew D Hammond; Lauren H Sansing; Louise D McCullough
Journal:  Exp Neurol       Date:  2013-08-29       Impact factor: 5.330

6.  Docosahexaenoic acid confers enduring neuroprotection in experimental stroke.

Authors:  Sung-Ha Hong; Ludmila Belayev; Larissa Khoutorova; Andre Obenaus; Nicolas G Bazan
Journal:  J Neurol Sci       Date:  2013-12-31       Impact factor: 3.181

7.  Intranasal Delivery of a Caspase-1 Inhibitor in the Treatment of Global Cerebral Ischemia.

Authors:  Ningjun Zhao; Xiaoying Zhuo; Yujiao Lu; Yan Dong; Mohammad Ejaz Ahmed; Donovan Tucker; Erin L Scott; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2016-08-13       Impact factor: 5.590

8.  The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.

Authors:  Chen Zhang; Jie An; Dudley K Strickland; Manuel Yepes
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

9.  Intrathecal corticoids in permanent focal cerebral ischemia in rats. Part I: a new therapeutic approach in the acute phase.

Authors:  Sophia L Goericke; Tobias Engelhorn; Michael Forsting; Ulrich Speck; Stefan Maderwald; Mark E Ladd; Arnd Doerfler
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

10.  Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia.

Authors:  Lisa C Hoyte; Keith J Brooks; Simon Nagel; Asim Akhtar; Ruoli Chen; Sylvie Mardiguian; Martina A McAteer; Daniel C Anthony; Robin P Choudhury; Alastair M Buchan; Nicola R Sibson
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.